NCT07192614: A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Prostate Cancer